Friday 6 November 2026 Export BDX’s income statement to Excel — free account

Becton, Dickinson and Company

BDX Healthcare Medical Instruments & Supplies

Becton, Dickinson and Company’s revenue for fiscal 2025 (year ended September 2025) was $21.8 billion, up 8.24% from fiscal 2024.

Revenue: −9.55%
EPS: −31.5%
Free cash flow: −31.6%
Total debt: −22.9%

Quarter to June 2026, against a year earlier

212.15 1.40 −0.66%

Follow BDX

Alert me

Market cap: $58.2B
P/E: 64.1×
Fwd P/E: 39.2×
Dividend yield: 1.87%
F-score: 7/9
Altman Z: 1.85
Beneish M: −2.64
Dividend safety: 67/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Becton, Dickinson and Company (BDX) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, Becton, Dickinson and Company (BDX) trades at a price to free cash flow of 18.3×. Over the past ten years it has ranged from 11.3× (June 2026) to 55.9× (April 2022); the current reading is higher than 39% of that period. That is below the Medical Instruments & Supplies industry median of 23.5× and below the Healthcare sector median of 21.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/BDX/price-to-free-cash-flow" width="100%" height="360" style="border:0" loading="lazy" title="Becton, Dickinson and Company price to free cash flow, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/BDX/metrics/price-to-free-cash-flow">Becton, Dickinson and Company (BDX) price to free cash flow — stockrow.com</a></p>

Period	Price to free cash flow	Change
FY2025	16.1×	(9.97%)
FY2024	17.9×	(35.77%)
FY2023	27.9×	(17.74%)
FY2022	33.9×	78.45%
FY2021	19.0×	(18.99%)
FY2020	23.5×	4.05%
FY2019	22.6×	(17.01%)
FY2018	27.2×	47.07%
FY2017	18.5×	17.61%
FY2016	15.7×	(0.42%)

Period	Price to free cash flow	Change
Jun 2026	13.0×	2.83%
Mar 2026	12.6×	(25.11%)
Dec 2025	16.9×	4.47%
Sep 2025	16.1×	(15.33%)
42 more quarters	Free account

Against its own ten years

Low 11.3× High 55.9×

Ten-year median 20.5×

Current reading's percentile 39

Company	Price to free cash flow
SOLV Solventum Corporation compare	n/m
MDLN Medline Inc. compare	11.3×
BAX Baxter International Inc. compare	11.6×
COO The Cooper Companies, Inc. compare	18.1×
BDX Becton, Dickinson and Company	18.3×
RMD ResMed Inc. compare	21.5×
ALC Alcon compare	23.3×
ISRG Intuitive Surgical, Inc. compare	44.6×
WST West Pharmaceutical Services, Inc. compare	61.5×
Medical Instruments & Supplies industry median	23.5×
Healthcare sector median	21.1×
Market median	14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

Becton, Dickinson and Company (BDX) Price to free cash flow

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on BDX

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on BDX

Stockrow Weekly